Featured Research

from universities, journals, and other organizations

Behavioral Program Boosts Antibody That Fights Breast Cancer

Date:
September 1, 1999
Source:
Ohio State University
Summary:
Women with breast cancer who participated in a psychological intervention program showed lower levels of a stress hormone and higher levels of a antibody that fights breast tumors than did other patients, a new study has found.

COLUMBUS, Ohio -- Women with breast cancer who participated in a psychological intervention program showed lower levels of a stress hormone and higher levels of a antibody that fights breast tumors than did other patients, a new study has found.

In addition, women in the program were more likely than others to get the full dosage of their chemotherapy, and showed lower levels of depression and reported higher quality of life.

The results suggest that the program -- which included training in relaxation, stress reduction, and coping strategies -- may not only aid women psychologically, but may also help them fight their disease, said Barbara Andersen, leader of the study and professor of psychology at Ohio State University.

"The bright and encouraging news is that psychological interventions have reliable biological effects that can benefit women with breast cancer," Andersen said.

"To our knowledge, these are the first experimental data to show a link between psychological interventions and an immune response directly related to fighting breast cancer." She presented the results Aug. 21 in Boston in an invited address at the annual meeting of the American Psychological Association. Andersen and her colleagues examined 115 women with Stage II or Stage III breast cancer. Half of the women were enrolled in the intervention, which included social support, training in progressive muscle relaxation, encouragement to exercise regularly and information on improving diet. The other half didn't participate in the intervention. Researchers found that women in the intervention program showed significantly lower levels of the stress hormone cortisol at four and eight months after surgery than did breast-cancer patients who didn't participate. (Cortisol levels were about one-quarter lower in program participants at eight months.) "Stress hormones such as cortisol are known to depress the immune system, so it is very significant the women who participated in the program show lower levels of cortisol," Andersen said. Program participants also showed significantly higher levels (about one-quarter higher) of an antibody to mucin, a chemical which at high levels is associated with the severity and progression of breast cancer. Andersen said mucin antibody levels declined in both groups during the stress of chemotherapy. However, women who participated in the intervention program generally saw their antibody levels rebound at eight and 12 months after surgery. But antibody levels remained low for non-participants. The fact that the mucin antibody response was stronger in program participants suggests that other anti-tumor responses may also be stronger in these women. "We suspect that the overall immune response is stronger in women who took part in the intervention," Andersen said. Another encouraging finding was that program participants also received a significantly larger dose of some chemotherapy drugs -- methotrexate and 5-FU -- than did other patients. Although women in both groups were initially prescribed similar doses of chemotherapy drugs, Andersen said women who didn't receive the intervention were more likely to have their dosage reduced because of severe nausea and vomiting or because they simply refused the treatment. For example, women in the intervention group who didn't comply with their chemotherapy were about 10 times less likely to say it was because of nausea or vomiting. Overall, about twice as many non-participants refused chemotherapy as did program participants. "The intervention program helps women tolerate their chemotherapy better so they can stay on track and receive the full dosage," Andersen said. The program also helped women on a wide variety of psychological and social measures, Andersen said. Compared to other patients, participants reported less depression, more energy and even more social support from their friends. "We're finding that stress and distress can be significantly reduced in breast-cancer patients and that these effects are linked to lowering of stress hormones, a stronger immune response, and a better quality of life," Andersen said. This study is part of the ongoing Stress and Immunity Breast Cancer Project headed by Andersen. Other investigators include Olivera Finn of the University of Pittsburgh and William Malarkey and William Farrar of Ohio State. Charles Emery, also of Ohio State, presented some of the exercise-related results at the APA meeting. Among those funding the study are the American Cancer Society, The Longaberger Company, U.S. Army Medical Research, National Institute of Mental Health, the Walther Cancer Foundation, and Ohio State's Elizabeth Gee Fund.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Behavioral Program Boosts Antibody That Fights Breast Cancer." ScienceDaily. ScienceDaily, 1 September 1999. <www.sciencedaily.com/releases/1999/09/990901081334.htm>.
Ohio State University. (1999, September 1). Behavioral Program Boosts Antibody That Fights Breast Cancer. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/1999/09/990901081334.htm
Ohio State University. "Behavioral Program Boosts Antibody That Fights Breast Cancer." ScienceDaily. www.sciencedaily.com/releases/1999/09/990901081334.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins